Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.	Digestive System Diseases, pancreas disorder, pancreatitis, recurrent acute pancreatitis	Recruiting	Phase 2	2026-07-29		NCT06253117

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Congressionally Directed Medical Research Programs	87
University of Alabama at Birmingham	467

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mayo Clinic	Rochester	United States	664
University of Alabama at Birmingham	Birmingham	United States	247
University of Iowa Health Care	Iowa City	United States	47

Clinical trials